Format

Send to

Choose Destination
Prim Care Diabetes. 2019 Sep 30. pii: S1751-9918(19)30327-4. doi: 10.1016/j.pcd.2019.09.004. [Epub ahead of print]

Vaccination adherence to influenza, pneumococcal and hepatitis B virus in adult type 1 diabetes mellitus patients.

Author information

1
Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain. Electronic address: jmorenof@sescam.jccm.es.
2
Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain.
3
Ciudad Real Medicine School, Castilla-La Mancha University, Ciudad Real, Spain.
4
Córdoba Medicine School, Córdoba University, Córdoba, Spain.
5
Translational Research Unit, Ciudad Real University Hospital, Ciudad Real, Spain.

Abstract

AIM:

To document adherence to influenza, pneumococcal and hepatitis B virus (HBV) vaccination programme in adult type 1 diabetes mellitus (T1DM) patients.

MATERIALS AND METHODS:

Observational retrospective study using data obtained from computerized clinical records. We contacted all adult T1DM registered in our database from a tertiary diabetes care hospital. Primary efficacy outcome was to describe influenza, pneumococcal and HBV vaccination status.

RESULTS:

Three hundred patients were analyzed (male 53%). Mean age was 40.0±14.4years and T1DM duration was 19.7±11.8years. Thirty-five percent of the patients had complementary indications for studied vaccines. Adherence to vaccination program for influenza, pneumococcal and HBV was achieved by 55%, 18% and 17% of the patients, respectively. Only 3% of the subjects were vaccinated against the three microorganisms. Predictor of correct vaccination were: age, shorter diabetes duration, insulin pump treatment, better diabetes control and being a health professional. We detected 17 sick leaves, 127 lost working days and 3 hospitalizations due to flue during the follow-up.

CONCLUSIONS:

The uptake of recommended vaccinations against influenza, pneumococcal and HBV in adult T1DM patients was below desirable levels. A special effort is required to all health professionals to implement immunization among adult people with T1DM. Clinical Trials NCT03478254.

KEYWORDS:

HBV; Influenza; Pneumococcal; Type 1 diabetes; Vaccination

PMID:
31582202
DOI:
10.1016/j.pcd.2019.09.004

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center